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Abstract
The automation of adverse drug reac-
tion (ADR) detection in social media
would revolutionize the practice of phar-
macovigilance, supporting drug regula-
tors, the pharmaceutical industry and the
general public in ensuring the safety of
the drugs prescribed in daily practice.
Following from the published proceed-
ings of the Social Media Mining for
Health (SMM4H) Applications Workshop
& Shared Task in August 2019, we aimed
to develop a deep learning model to clas-
sify ADRs within Twitter tweets that con-
tain drug mentions. Our approach in-
volved fine-tuning BERTLARGE and two
domain-specific BERT implementations,
BioBERT and Bio + clinicalBERT, apply-
ing a domain-specific preprocessor, and
developing a max-prediction ensembling
approach. Our final model resulted in
state-of-the-art performance on both F1-
score (0.6681) and recall (0.7700) outper-
forming all models submitted in SMM4H
2019 and during post-evaluation to date.
1 Introduction
Adverse drug reactions are one of the leading
causes of hospitalizations and deaths globally.
New pharmaceuticals are approved by the FDA
with limited clinical data relative to the size of the
populations subsequently prescribed these drugs,
making their real-world safety profile uncertain.
Current methods for ADR monitoring such as
post-marketing surveillance studies do not take ad-
vantage of the wealth of information shared by the
public on the internet, resulting in an untapped op-
portunity for automatic detection and extraction of
this information from social media platforms such
as Twitter. Existing models underperform in this
context due to misspellings and frequent use of
idiomatic, ambiguous and sarcastic expressions in
social media (Sarker and Gonzalez, 2015).
When considering evaluation criteria it is im-
portant to take into account the context of the po-
tential use case. The value of automatic ADR
detection in social media for pharmacovigilance
will be for (1) identifying novel ADRs in a wider
population not currently identified by more tradi-
tional data collection means and (2) increasing the
speed by which ADRs are identified. In the con-
text of Twitter, drug use mentions are rare with less
than 1% of all tweets even mentioning drug names
(Meng et al., 2017), with our dataset further high-
lighting that less than 10% of these drug-related
tweets may represent ADR mentions. For these
reasons, we argue that recall is the most important
performance metric given the focus on identifying
all true ADRs. Whilst precision is relevant, it is
not critical since false postive ADRs can be fil-
tered out in downstream tasks, so there is limited
harm in falsely identified ADRs while there is sig-
nificant public good in correctly identifying ADRs
which may not be identified as readily using cur-
rent methods.
Our study aims to achieve state-of-the-art re-
sults, specifically on F1-score and recall, on a
dataset used as part of an annual competition on
classifying Twitter tweets as either reporting an
adverse drug reaction or not. We use BERTLARGE
as our baseline, with hyperparameters selected
based on the 2019 winning teams model. For our
contribution, we fine-tuned two domain-specific
BERT implementations, BioBERT (Lee et al.,
2019) and Bio + clinicalBERT (Alsentzer et al.,
2019), applied a domain-specific preprocessor,
and developed a novel ensembling approach.
2 Background
The first notable attempts at classifying ADRs
from Twitter were published in 2015 (Sarker and
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Table 1: Preprocessor Components and Description
Component Description
Anonymize Replaces URLs with ”-URL-”, removes usernames from email addresses while retaining the email
domain, and removes copyright and trademark logos
Replace handles Replaces twitter handles with -TH-
Remove hashtags If word starts with #, remove # symbol but keep the word
Lowercase Converts tokens to lowercase (required for Drug Normalizer step)
Drug normalize Converts drug brand names to generic names
Gonzalez, 2015) applying natural language pro-
cessing techniques for feature extraction and tra-
ditional machine learning models such as sup-
port vector machine classifiers. Following this,
an annual meeting entitled Social Media Mining
for Health (SMM4H) Applications Workshop &
Shared Task arose which has met over four con-
secutive years, with the latest meeting in August
2019. An annotated corpus of tweets has devel-
oped alongside this work, currently consisting of
25,678 labeled tweets available for training and an
additional 4,575 tweets used for model evaluation
as part of the ongoing competition (Weissenbacher
et al., 2019).
The most recent meeting of SMM4H con-
firmed that techniques used to tackle this task have
evolved alongside the developments in deep learn-
ing architectures more generally, with the 2018
dominance of convolutional and recurrent neu-
ral networks being overtaken in 2019 with neural
architectures using word embeddings pretrained
with Bidirectional Encoder Representations from
Transformers (BERT) (Devlin et al., 2019). The
performance on classifying tweets improved from
0.522 F1-score (0.442 precision, 0.636 recall) in
SMM4H 2018 to 0.646 F1-score (0.608 precision,
0.689 recall) in SMM4H 2019 (Weissenbacher
et al., 2019). The winning teams approach in-
volved retraining BERT on a large-scale unlabeled
corpus of 1.5 million tweets extracted from Twit-
ter based on the 150 drug names collected from the
training set (Chen et al., 2019). While these are the
highest scores seen to date on this dataset, there
is still room for improvement on this task. One
such improvement of the BERT-based models pre-
sented at SMM4H 2019 could be the inclusion of
domain-specific preprocessing, with one approach
by Dirkson et al (2019) for lexical normalization
of medical social media data achieving a 0.8% re-
duction in out-of-vocabulary terms on spell cor-
rection tasks in cancer-related patient forums.
Table 2: Examples of Erroneous Alterations Due to Prepro-
cessor Spell Corrector
Original Altered Likely Intended Meaning
gerd germs Gastroesophageal reflux disease
imigran migraine Brand name for Sumatriptan
lovan prozac Brand name for Fluoxetine
3 Methods
Our models were built using the TensorFlow im-
plementation of BERT with cTPU on Google Co-
lab, loosely based on code published by Dhar-
mendra Choudhary (Choudhary, 2019). Our base-
line model uses BERTLARGE with a single addi-
tional affine layer and sigmoid for the ADR clas-
sification task with hyperparameters selected from
the SMM4H 2019 winning team of Chen et al
(2019). Three BERT-based models were then im-
plemented with identical but alternative hyperpa-
rameters selected relative to our baseline model:
• BERTLARGE, uncased
• BioBERT; initialized from BERTBASE and
pre-trained on biomedical corpora, including
PubMed abstracts (4.5B words) and Pubmed
Central/PMC full-text articles (13.5B words)
• Bio + clinicalBERT (known from here on-
wards just as ClinicalBERT); initialized from
BioBERT, then pre-trained on 2M clinical
notes
Our preprocessing approach was inspired by the
lexical normalization method proposed by Dirk-
son et al (2019). It includes several components
which clean tweets and a drug normalizer module
to convert brand names of drugs to their generic
equivalent utilizing Dirksons DrugNorm method
(2019). The full list of components used in our
final preprocessor are described in Table 1.
Notably, despite the success of the spell cor-
rector component in reducing out-of-vocabulary
terms in previous research, we decided to exclude
it from our model due to our determination that
an unacceptable number of erroneous alterations
to the text were resulting from its use (see Table 2
for examples).
Figure 1: Final Ensembling Approach
We split our training set 80/20 into training and
dev sets for the purposes of fine-tuning our mod-
els. Due to the model variability resulting from
each fine-tuning run of the training set (described
further in the Results & Discussion section), we
ran five models for each model type. We then ap-
plied an ensembling method that included averag-
ing the predicted probabilities across runs, then
using a maximum positive probability ensemble
technique, whereby we predicted the positive class
for a tweet if any of the three included models pre-
dicted the positive class (see Figure 1).
Our final approach was evaluated by fine-tuning
our models on the full training set (25,678 tweets)
and then evaluating these on a test dataset (4,575
tweets) on the post-evaluation competition plat-
form (SMM4H, 2019). Key performance metrics
are consistent with the SMM4H 2019 competition:
F1-score, precision, and recall. However, we pri-
oritized optimizing recall over precision for rea-
sons described in our Introduction section.
4 Results
4.1 Baseline models
Our baseline model, using the SMM4H winning
teams model parameters but without their corpus
for retraining, reported as ”BERT noRetrained”
(Chen et al., 2019), struggled with convergence
for roughly 30% of the models trained, resulting in
F1-scores of 0, given that it predicted the negative
class during evaluation for every test example. We
therefore ran the model multiple times and only
included the results of the first five models with
non-zero scores as our baseline. The results of the
five converging baseline models on the test set and
their average are presented in Table 3. Notably,
the F1-score is nearly identical to that reported by
Chen et al (2019). Due to this convergence issue,
Table 3: Average Prediction on Test set for Baseline BERT
1 2 3 4 5 Avg Chen1
F1 0.59 0.63 0.62 0.63 0.62 0.618 0.618
P 0.64 0.66 0.64 0.66 0.67 0.654 0.646
R 0.55 0.61 0.61 0.60 0.57 0.587 0.593
1 based on Chen 2019’s dev set
we decreased our learning rate from 5e-5 to 2e-5
for our subsequent models.
Additionally, we discovered that the number of
epochs set at 20 was unnecessary for our mod-
els, likely due to the relatively small size of our
dataset. While the loss after the first epoch ranged
between 0.001 and 1.0, by the fourth epoch our
training loss would consistently drop below 0.001
(see Figure 2). We consequently reduced this hy-
perparameter to 8 to reducing training time.
Figure 2: Training Loss After Each Epoch for 5 Runs on
BioBERT with Preprocessor
4.2 Model variability analysis
We hypothesized that the variability in predictions
observed as part of our baseline model were due
either to the relatively small training set or due
to the general rarity of positive examples in our
corpus. Four alternative model specifications, and
some combinations of these four alternatives, were
Table 4: Standard Deviations from 5 Runs on Scenarios Aimed to Reduce Variability in Performance
Index Scenario BERT LARGE1 BioBERT
F1 StDev Recall StDev F1 StDev Recall StDev
0 Original 0.014 0.017 0.007 0.015
1 Training set with 3x positive examples 0.010 0.024 0.011 0.011
2 Batch size = 128 0.013 0.022 0.004 0.011
3 Loss with 2x positive weights 0.007 0.013 0.011 0.017
4 Dropout = 0.2 0.012 0.022 0.007 0.006
5 1&2 combined 0.007 0.009 0.012 0.013
6 1&2&3&4: All combined 0.008 0.011 0.007 0.020
1 This version of BERTLARGE also included additional preprocessing which was not ultimately included in our final models
evaluated to determine if we could minimize this
variability. These four changes included:
1. Altering the training set by making two addi-
tional copies of each positive-label example
(i.e. those labeled as an ADR)
2. Increasing the batch size from 32 to 128
3. Adjusting our loss function to weigh posi-
tive weights three times higher than negative
weights
4. Increasing the dropout rate from 0.1 to 0.2
Each scenario was run 5 times on our dev set
with the output metric being the standard devia-
tion for both F1-score and recall. These were run
over both BERTLARGE and BioBERT models and
presented in Table 4.
This analysis did not uncover any consistent
themes on approaches that could reduce the vari-
ability observed within the model predictions.
Furthermore, given that no other model outputs
showed cause for concern, we accepted this vari-
ability as a consequence of our particular task and
managed this issue by taking the average predic-
tion from five model runs for each of our final
BERT models.
Figure 3: Sources of False Positives and True Positives: Max
Ensemble on Dev Set with Preprocessor
4.3 Final models
The average prediction results, based on five runs
of each model, for each of our six model types
(BERTLARGE, BioBERT, ClinicalBERT with and
without our preprocessor) are presented in Ta-
ble 5. BERTLARGE outperformed BioBERT and
ClinicalBERT on all performance metrics when no
preprocessor was applied with F1-scores of 0.65,
0.59, and 0.58 respectively. However, the differ-
ence in performance lessened considerably when
the preprocessor was applied, with ClinicalBERT
in particular observing improved predictions, with
F1-score increasing from 0.58 to 0.62 and recall
increasing from 0.55 to 0.61.
Despite the poorer performance of BioBERT
and ClinicalBERT, ensemble methods demon-
strate that these alternative representations capture
additional information which BERTLARGE does
not. This is demonstrated in Figure 3 where 16.3%
of true positives in our dev set with preproces-
sor ensemble were captured by either BioBERT
or ClinicalBERT but not BERTLARGE. Our best
performing model resulted from ensembling the
three BERT models with preprocessor as seen in
Table 5 with F1-score increasing by 0.02 and re-
call increasing by a substantial 0.16 points relative
to our BERTLARGE model.
The ClinicalBERT and BioBERT models con-
tributed a high percentage of false positives rel-
ative to BERTLARGE (Figure 3). In an attempt
to reduce the number of false positives, we ex-
perimented with threshold tuning. We found
that implementing a threshold of 0.6 for the
BioBERT and ClinicalBERT models and 0.5 for
the BERTLARGE model resulted in a higher F1-
score and higher recall on our training data. How-
ever, when we evaluated the models on our test
data, we found that a threshold of 0.5 for all mod-
els performed slightly better in terms of F1-score
and recall. We believe the threshold tuning re-
Table 5: Average Prediction for BERTLARGE, BioBert, ClinicalBert and Max Ensemble Results with and without Preprocessor
No preprocessor BERT BioBERT ClinicalBERT Max Ensemble
F1-score 0.6446 0.5915 0.5809 0.6378
Precision 0.6695 0.6200 0.6180 0.5663
Recall 0.6214 0.5655 0.5479 0.7300
Preprocessor BERT PP BioBERT PP ClinicalBERT PP Max Ensemble PP
F1-score 0.6475 0.6153 0.6212 0.6681
Precision 0.6907 0.6577 0.6360 0.5900
Recall 0.6097 0.5793 0.6076 0.7700
sulted in overfitting the model to the training data,
thus we used the standard threshold of 0.5 for all
models in the final ensemble.
5 Discussion
Our research suggests that ensembling vari-
ous BERT implementations (general domain
BERTLARGE and domain-specific BioBERT and
ClinicalBERT) and applying a simple domain-
specific preprocessing technique can improve pre-
dictions for ADR classification in social media.
Our best ensemble model has a recall of 0.770
compared to baseline of 0.587 and F1-score of
0.668 compared to baseline of 0.618. This model
outperformed the best results on both metrics pre-
sented at the August 2019 meeting of SMM4H
as well as exceeded all results submitted on the
competition platform since the meeting in post-
evaluation (as of March 21, 2020).
Notably, our BERTLARGE model with prepro-
cessor performed as well as the SMM4H 2019
winning team’s model, which involved retraining
BERTLARGE on a sizable Twitter corpus. This sug-
gests that simple preprocessing techniques are still
valuable to implement in the context of state-of-
the-art representation models such as BERT. Of
all components in our preprocessor, we believe
the drug normalizer, which translates brand names
of drugs into generic names, is the most impor-
tant. After examining the outputs of models with
no preprocessor, we noticed that many of the false
negative examples contained the brand name of a
drug, rather than the generic name. The generic
names of drugs often contain similar suffixes for
drugs in the same family, so when the BERT to-
kenizer is applied it is able to create more mean-
ingful tokens from the generic drug names. For
example, quetiapine (que ##tia ##pine) and olan-
zapine (o ##lan ##za ##pine) both share the same
last token (##pine), while their brand name equiv-
alents, Seroquel (se ##ro ##quel) and Zyprexa (z
##y ##p ##re ##xa), have no tokens in common.
We hypothesize this ability to create more mean-
ingful, generalizable tokens is why the addition of
the drug normalizer improved the F1-score and re-
call for models pretrained on biomedical corpora
(BioBERT and ClinicalBERT) by 2.4% - 10.9%.
While the preprocessor did not have a similar ef-
fect on F1-score and recall for BERTLARGE, this is
expected as brand names of drugs are often more
commonly used outside of biomedical corpora.
Despite our efforts to identify a way to mini-
mize the variability in model predictions, each of
our final models continue to have a standard devi-
ation of approximately 0.01 which we attribute to
the skewness of the classification task at hand and
the limited amount of training data available. It is
likely that other researchers who developed BERT-
based models for this task may have suffered from
similar challenges as this variance in accuracy is
a known issue for BERT models trained on small
datasets (Devlin et al., 2019). It was due to this
variability that our ensembling approach begins by
taking an average prediction of 5 trained models
for each of our three BERT models, which effec-
tively operates as a majority vote for each classifi-
cation. Ensembling according to the max predic-
tion across the resulting BERTLARGE, BioBERT
and ClinicalBERT ensembled models ensured we
maximized recall by taking information distinctly
gleaned from each of these three model.
6 Conclusion
This study aimed to develop a state-of-the-art ad-
verse drug reaction (ADR) detection deep learning
model for social media. Our contribution has been
the development of a BERT-based deep learning
model combining improved domain-specific pre-
processing and ensembling which has resulted in
state-of-the-art results for this ADR classification
task. This study also provided a clear illustration
of the variability that can be expected when fine-
tuning BERT models on small datasets and some
practical considerations for how to overcome this
variability through averaging. Despite our success
in developing this model, we identified two main
limitations associated with this work in the context
of its ideal use case which is the real time moni-
toring of social media platforms for ADRs. Firstly,
such a large ensemble model may not be realistic
to put into production and indeed alternative meth-
ods such as simpler single-layer BiLSTM distilled
from BERT-based models (Tang et al., 2019) may
be more suited to a real-time task. Secondly, this
classification task only represents the first task that
should be automated, with ADR mention extrac-
tion and normalization also required. The perfor-
mance of existing models to perform these down-
stream tasks have considerable room for improve-
ment (Weissenbacher et al., 2019) and should be
the focus of further research.
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